Fitbit for the flu: Researchers show the fitness wearables can help track outbreaks

Fitbit- updated
Using de-identified data from more than 47,000 Fitbit users across five states, researchers were able to evaluate over 13.3 million daily measurements and track deviations from each individual's personal norm. (Fitbit)

A new study showed that by employing secondary signals from heart rates, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu in real time and better than current infectious disease surveillance methods.

People’s resting heart rates tend to be faster when they’re sick with a disease like influenza and are paired with changes in sleep routines and, of course, a tendency to be more sedentary than usual, according to research published in The Lancet Digital Health.

Using de-identified data from more than 47,000 consistent Fitbit users across five states, researchers were able to evaluate over 13.3 million daily measurements. By tracking deviations from their personal norms, they compared the proportion of users with abnormal readings to weekly estimates of flu-like illness rates from the Centers for Disease Control and Prevention.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

RELATED: Google shells out $2.1B for Fitbit and its health-focused wearables

Across each state, data from Fitbit trackers helped improve influenza predictions. While additional prospective studies will be needed to differentiate between infectious versus non-infectious disease forecasting, traditional flu surveillance methods may take from one to three weeks—greatly limiting the measures clinicians can take to respond to an outbreak.

"Responding more quickly to influenza outbreaks can prevent further spread and infection, and we were curious to see if sensor data could improve real-time surveillance at the state level,” study author Jennifer Radin of the Scripps Research Translational Institute said in a statement.

“We demonstrate the potential for metrics from wearable devices to enhance flu surveillance and consequently improve public health responses,” said Radin. “In the future as these devices improve, and with access to 24/7 real-time data, it may be possible to identify rates of influenza on a daily instead of weekly basis."

RELATED: Fitbit enlists Pfizer, Bristol-Myers Squibb to bring arrhythmia detection to its fitness trackers

Additionally, larger volumes of data may make it possible to localize predictions at the county or city levels, researchers said. About 7% of working adults are diagnosed with the flu annually, as well as about 20% of children under five, according to previous studies. Meanwhile, surveys have estimated that 12% of consumers in the U.S. own a wearable fitness tracker or a smartwatch.

Suggested Articles

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.

ADC Therapeutics nearly went through the entire alphabet before trying, twice, to get off an IPO. Now, it’s looking to become a commercial biotech.